Translate

Wednesday 22 April 2015

Top stocks that need to be on your radar

Top stocks that need to be on your radar


Below are the stocks that should be on investors' radar

Natco Pharma When Teva Pharmaceuticals Industries made an unsolicitated offer to buyout Mylan for USD 40 billion in cash and stock, it ruffled shareholders of Natco Pharma . Natco has teamed up with Mylan to challenge the validity of Teva’s key patent related to 20 mg dosage version of Copaxone in US courts. Copaxone, with sales of USD 4 billion a year accounts for 50 percent of Teva’s profit, is due to expire in September.

WIPRO Wipro's fourth quarter (January-March) consolidated profit jumped 3.6 percent to Rs 2,272 crore and revenue increased by 0.7 percent to Rs 12,171.4 crore compared to December quarter. The country's third largest software services exporter missed street expectations on IT services revenues front that declined 1.2 percent sequentially to USD 1.77 billion in the quarter ended March 2015. Rupee revenues fell 0.9 percent quarter-on-quarter to Rs 11,242 crore for the quarter.

VST Industries The company reported mixed earnings for the quarter ended March 2015. The topline growth was healthy, largely led by prices; the margins were weak clubbed with fall in PAT.

Persistent Systems The company beat street expectations on bottomline front but the topline slightly missed estimates. Net profit grew 2.1 percent sequentially to Rs 76.05 crore and revenue increased by 0.6 percent to Rs 497.4 crore during January-March quarter.

CIMMCO The company an subsidiary of Titagarh Wagons received industrial license to manufacture various items for defence. The equipment will be manufactured from unit at Bharatpur in Rajasthan.

Tyre Stocks With the international rubber prices seeing a sharp rise in last two days, tyre companies are likely to be in focus. Moreover, crude oil too was up 8 percent in last five trading session and rise in crude oil would lead to higher synthetic rubber prices. However, prices of domestic natural rubber continue to be subdued.

Sun Pharma Aranda Investment Maurtius bought 2 crore shares at Rs 930.16 per share. Goldman Sachs (Singapore) bought 5.12 cr shares at Rs 930.16/share. The Government of Singapore too bought 1.26 cr shares at Rs 930.16/share. However, Daiichi Sankyo sold 21.4 cr shares at Rs931.58/sh. The company clarified that Dilip Shanghvi has not purchased shares of the company with respect to Daiichi stake sale. JP Morgan is overweight on the stock with a target price of Rs 1030.

SBI The stock has consistently seen some delivery based buying. PSU banks this month have been the gainers and private banks have been loosed because of the valuation trade.

Happy Investing
Source : Moneycontrol.com

No comments:

Post a Comment